May 21, 2026
PHRI team at SCT 2026
Over three days, members of the PHRI team joined researchers from around the world at the Society of Clinical Trials...
Read More
May 20, 2026
Thomas Scheier recognized with Siegenthaler Return Grant
For Thomas Scheier, PHRI investigator, his research journey began with a simple but important observation. Early in his residency in...
Read More
May 14, 2026
Building Bridges Symposium 2026
PHRI researchers, staff, and research fellows took part in this year’s Building Bridges Symposium, sharing their work alongside colleagues from...
Read More
May 11, 2026
PHRI at ESOC 2026
PHRI researchers took the stage at the European Stroke Organisation Conference (ESOC) 2026, held on May 6-8 in Maastricht, Netherlands....
Read More
May 5, 2026
Upcoming presentations at ESOC 2026
PHRI researchers will be presenting their work at the European Stroke Organisation Conference (ESOC) 2026, taking place May 6-8 in Maastricht, Netherlands....
Read More
April 16, 2026
New anti-clotting medication lowers risk of stroke without added bleeding
PHRI researchers have found asundexian, an investigational anti‑clotting medication, reduces the risk of a stroke in people who recently experienced...
Read More